A comprehensive approach might combine peptides that address inflammation, tissue repair, and immune regulation simultaneously
What is missing: in-person evaluation, comprehensive lab work, hands-on injection training
Subcutaneous injection into abdominal fat or near the site of injury (as commonly practiced by self-experimenters) is the most reported approach, but this is not a clinical protocol
As an intramuscular injection, onabotulinumtoxinA is endocytosed at presynaptic nerve terminals and cleaves soluble N-ethylmaleimide-sensitive-factor attachment protein receptor (SNARE) proteins involved in exocytosis, preventing the release of acetylcholine vesicles into the neuromuscular junction
The interaction is likely pharmacodynamic rather than pharmacokinetic, and no formal human data exist
BPC-157 amplifies growth hormone activity not by increasing hormone levels but by upregulating the receptors that respond to it